Oaktree is going of on a tangent and has got his long bow out.

could this be the reason Biotron took out the Hep C patent below this year? The patent does references this earlier work by GAGE

Link Sars Cov 2 and Dengue. Next Gen

Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770470/

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Hepatitis c antiviral compositions and methods

US20200385340A1 - Hepatitis c antiviral compositions and methods - Google Patents
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Dengue Virus M Protein C-Terminal Peptide (DVM-C) Forms Ion Channels

• A. Premkumar,
• C. R. Horan &
• P. W. Gage

Dengue Virus M Protein C-Terminal Peptide (DVM-C) Forms Ion Channels | SpringerLink